Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Alessi JV"'
Autor:
Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Gandhi MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Elkrief A; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY., Ladanyi M; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY., Vanderbilt C; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY., Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Aldea M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Barrichello A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Saini A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Sholl L; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Sands JM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Oct; Vol. 8, pp. e2400394. Date of Electronic Publication: 2024 Oct 07.
Autor:
Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston., Alden SL; Johns Hopkins School of Medicine, Baltimore., Smithy JW; Memorial Sloan Kettering Cancer Center, New York., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston., Wang X; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston., Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston., Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston., Gandhi MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston., Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston., Spurr LF; Pritzker School of Medicine, University of Chicago, Chicago; Department of Radiation and Cellular Oncology, University of Chicago, Chicago., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston., Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston., Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston; Cancer Program, Broad Institute of MIT and Harvard, Cambridge., Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston; Cancer Program, Broad Institute of MIT and Harvard, Cambridge., Nishino M; Department of Radiology, Brigham and Women's Hospital, Boston; Department of Imaging, Dana-Farber Cancer Institute, Boston, USA., Johnson BE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston. Electronic address: mark_awad@dfci.harvard.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Oct; Vol. 35 (10), pp. 902-913. Date of Electronic Publication: 2024 Jun 29.
Autor:
Scalera S; Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Marinelli D; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, United Kingdom., Mazzotta M; Medical Oncology Unit, Sandro Pertini Hospital, Rome, Italy., Cipriani L; Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bon G; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Schiavoni G; Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Terrenato I; Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Fanciulli M; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ciuffreda L; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., De Nicola F; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Goeman F; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Caravagna G; Department of Mathematics and Geosciences, University of Trieste, Trieste, Italy., Santini D; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Rome, Italy., De Maria R; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Cappuzzo F; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Jamal-Hanjani M; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.; Department of Medical Oncology, University College London Hospitals, London, United Kingdom., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., McGranahan N; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom., Maugeri-Saccà M; Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4397-4411.
Autor:
Ludin A; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute; Boston, MA, USA.; These authors contributed equally., Stirtz GL; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA.; These authors contributed equally., Tal A; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA., Nirmal AJ; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Ludwig Center at Harvard; Boston, MA, USA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA.; Department of Systems Biology, Harvard Medical School; Boston, MA, USA., Besson N; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Jones SM; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Manos M; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Liu S; Biophysics Program, Harvard University, Boston, MA 02115, USA.; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA., Barrera I; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Gong Q; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Rodrigues CP; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute; Boston, MA, USA., Sahu A; Dermatology Service, Memorial Sloan Kettering Cancer Center; New York, NY, USA.|., Jerison E; Department of Physics, University of Chicago, Chicago, IL 60637, USA, Institute for Biophysical Dynamics, and James Franck Institute., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Richardson DS; Harvard Center for Biological Imaging, Department of Molecular and Cellular Biology, Harvard University; Cambridge, MA, USA., Weiss JD; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA., Moreau HM; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA., Stanhope ME; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA., Afeyan AB; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA., Sefton J; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA., McCall WD; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA., Formato E; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute; Boston, MA, USA., Yang S; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute; Boston, MA, USA., Zhou Y; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute; Boston, MA, USA., van Konijnenburg DPH; Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Cole HL; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA., Cordova M; Dermatology Service, Memorial Sloan Kettering Cancer Center; New York, NY, USA.|., Deng L; Dermatology Service, Memorial Sloan Kettering Cancer Center; New York, NY, USA.|., Rajadhyaksha M; Dermatology Service, Memorial Sloan Kettering Cancer Center; New York, NY, USA.|., Quake SR; Department of Bioengineering and Applied sciences, Stanford University, Stanford, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chen F; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Sorger PK; Ludwig Center at Harvard; Boston, MA, USA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA.; Department of Systems Biology, Harvard Medical School; Boston, MA, USA., Hodi FS; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Parker Institute for Cancer Immunotherapy., Rodig SJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Murphy GF; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Zon LI; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Boston, MA, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute; Boston, MA, USA.; Howard Hughes Medical Institute, Harvard medical school; Boston MA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.
Autor:
Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nakazawa S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Harada G; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Lee JK; Foundation Medicine, Cambridge, Massachusetts., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Barrichello A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gandhi MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gazgalis D; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Feng WW; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Jiang J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Baldacci S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Locquet MA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gottlieb FH; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chen MF; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Lee E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Haradon D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Smokovich A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Voligny E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nguyen T; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Goel VK; Turning Point Therapeutics, Bristol Myers Squibb Company, San Diego, California., Zimmerman Z; Turning Point Therapeutics, Bristol Myers Squibb Company, San Diego, California., Atwal S; Turning Point Therapeutics, Bristol Myers Squibb Company, San Diego, California., Wang X; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts., Bahcall M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Heist RS; Massachusetts General Hospital, Boston, Massachusetts., Iqbal S; The Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts., Gandhi N; Caris Life Sciences, Phoenix, Arizona., Elliott A; Caris Life Sciences, Phoenix, Arizona., Vanderwalde AM; Caris Life Sciences, Phoenix, Arizona., Ma PC; Penn State Cancer Institute, Penn State College of Medicine, Penn State University, Hershey, Pennsylvania., Halmos B; Montefiore Einstein Cancer Center, Bronx, New York., Liu SV; Georgetown University, Washington, DC., Che J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schrock AB; Foundation Medicine, Cambridge, Massachusetts., Drilon A; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Aug 02; Vol. 14 (8), pp. 1440-1456.
Autor:
Wang X; Department of Environmental Health, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USA., Hou K; Bioinformatics Interdepartmental Program, University of California, Los Angeles, 611 Charles E. Young Drive, Los Angeles, CA, USA., Ricciuti B; Lowe Center for Thoracic Oncology and Center for Cancer Genomics, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Alessi JV; Lowe Center for Thoracic Oncology and Center for Cancer Genomics, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Li X; Department of Biostatistics, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USA; Department of Biostatistics, University of North Carolina at Chapel Hill, 135 Dauer Drive, Chapel Hill, NC, USA; Department of Genetics, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC, USA., Pecci F; Lowe Center for Thoracic Oncology and Center for Cancer Genomics, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Dey R; Department of Biostatistics, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USA., Luo J; Lowe Center for Thoracic Oncology and Center for Cancer Genomics, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Awad MM; Lowe Center for Thoracic Oncology and Center for Cancer Genomics, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Gusev A; McGraw/Patterson Center for Population Sciences, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Lin X; Department of Biostatistics, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USA., Johnson BE; Lowe Center for Thoracic Oncology and Center for Cancer Genomics, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Christiani DC; Department of Environmental Health, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA. Electronic address: dchris@hsph.harvard.edu.
Publikováno v:
HGG advances [HGG Adv] 2024 Jul 18; Vol. 5 (3), pp. 100320. Date of Electronic Publication: 2024 Jun 19.
Autor:
Cheong TC; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA. taekchin.cheong@childrens.harvard.edu., Jang A; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, 02115, USA., Wang Q; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA., Leonardi GC; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.; Department of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Lehtinen MK; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA., Harris MH; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA., Chiarle R; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA. roberto.chiarle@childrens.harvard.edu.; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, 10126, Italy. roberto.chiarle@childrens.harvard.edu.; Division of Hematopathology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy. roberto.chiarle@childrens.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 14; Vol. 15 (1), pp. 5110. Date of Electronic Publication: 2024 Jun 14.
Autor:
Chaunzwa TL; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Qian JM; Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Li Q; AstraZeneca, Cambridge, England and Waltham, Massachusetts., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nuernberg L; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.; Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands., Johnson JW; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts., Weiss J; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.; Department of Diagnostic and Interventional Radiology, University Freiburg, Freiburg im Breisgau, Germany., Zhang Z; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts., MacKay J; AstraZeneca, Cambridge, England and Waltham, Massachusetts., Kagiampakis I; AstraZeneca, Cambridge, England and Waltham, Massachusetts., Bikiel D; AstraZeneca, Cambridge, England and Waltham, Massachusetts., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mak RH; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Jacob E; AstraZeneca, Cambridge, England and Waltham, Massachusetts., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Aerts HJWL; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Jun 01; Vol. 10 (6), pp. 773-783.
Autor:
Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Elkrief A; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Lin J; Department of Medicine, Center for Thoracic Cancers, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Zhang J; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gandhi M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang X; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Makarem M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Murilo Hidalgo Filho C; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gorria T; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hospital Clinic de Barcelona, Barcelona, Spain., Saini A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Pabon C; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lindsay J; ImmunoProfile, Department of Pathology, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts., Pfaff KL; ImmunoProfile, Department of Pathology, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts., Welsh EL; ImmunoProfile, Department of Pathology, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts., Nishino M; Department of Radiology, Brigham and Women's Hospital and Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Kilickap S; Faculty of Medicine, Department of Internal Medicine and Medical Oncology, Istinye University Istanbul, Istanbul, Turkey., Rietschel P; Regeneron Pharmaceuticals, Tarrytown, New York., McIntyre DA; Regeneron Pharmaceuticals, Tarrytown, New York., Pouliot JF; Regeneron Pharmaceuticals, Tarrytown, New York., Altan M; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gainor JF; Department of Medicine, Center for Thoracic Cancers, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Heymach JV; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Schoenfeld AJ; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2024 Apr 12; Vol. 5 (9), pp. 100675. Date of Electronic Publication: 2024 Apr 12 (Print Publication: 2024).
Autor:
Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Puchala SR; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Mahadevan NR; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Lin JR; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Chowdhury A; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Li YY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA., Wang X; Harvard School of Public Health, Boston, MA., Spurr L; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA., Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Venkatraman D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Barrichello AP; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Gandhi M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Pangilinan AJ; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Haradon D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Lee E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Gupta H; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Welsh EL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Nishino M; Department of Radiology, Brigham and Women's Hospital, Boston, MA., Cherniack AD; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Johnson BE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Weirather JL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Dryg ID; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Sorger P; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Umeton R; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. 1311-1321. Date of Electronic Publication: 2024 Jan 11.